281 related articles for article (PubMed ID: 17579222)
1. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Shivnani AT
JAMA; 2007 Jun; 297(23):2581-2; author reply 2582. PubMed ID: 17579222
[No Abstract] [Full Text] [Related]
2. [Pancreatic carcinoma--overcome technically but not oncologically].
Herfarth Ch
Chirurg; 2003 Mar; 74(3):163-4. PubMed ID: 12722765
[No Abstract] [Full Text] [Related]
3. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
Lluís F
Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
[No Abstract] [Full Text] [Related]
4. Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
Abbruzzese JL
JAMA; 2008 Mar; 299(9):1066-7. PubMed ID: 18319419
[No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Maisonneuve P; Lowenfels AB
JAMA; 2007 Jun; 297(23):2581; author reply 2582. PubMed ID: 17579223
[No Abstract] [Full Text] [Related]
6. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for pancreatic cancer: one small step forward.
Benson AB
JAMA; 2007 Jan; 297(3):311-3. PubMed ID: 17227984
[No Abstract] [Full Text] [Related]
8. [Pancreatic cancer--diagnostics and therapy].
Schramm H
Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632
[No Abstract] [Full Text] [Related]
9. [Chemoradiation for pancreatic adenocarcinoma].
Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant and neoadjuvant therapy in curable pancreatic cancer.
Nugent FW; Stuart K
Surg Clin North Am; 2010 Apr; 90(2):323-39. PubMed ID: 20362789
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer.
Clin Evid; 2003 Jun; (9):528-33. PubMed ID: 12967377
[No Abstract] [Full Text] [Related]
12. Trial of adjuvant gemcitabine for pancreatic cancer: the jury is still out.
Palmer DH
Pancreatology; 2007; 7(5-6):548; author reply 549. PubMed ID: 17901720
[No Abstract] [Full Text] [Related]
13. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
Small W; Berlin J; Freedman GM; Lawrence T; Talamonti MS; Mulcahy MF; Chakravarthy AB; Konski AA; Zalupski MM; Philip PA; Kinsella TJ; Merchant NB; Hoffman JP; Benson AB; Nicol S; Xu RM; Gill JF; McGinn CJ
J Clin Oncol; 2008 Feb; 26(6):942-7. PubMed ID: 18281668
[TBL] [Abstract][Full Text] [Related]
14. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
15. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
Oettle H; Post S; Neuhaus P; Gellert K; Langrehr J; Ridwelski K; Schramm H; Fahlke J; Zuelke C; Burkart C; Gutberlet K; Kettner E; Schmalenberg H; Weigang-Koehler K; Bechstein WO; Niedergethmann M; Schmidt-Wolf I; Roll L; Doerken B; Riess H
JAMA; 2007 Jan; 297(3):267-77. PubMed ID: 17227978
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy in pancreatic cancer].
Láng I
Orv Hetil; 2004 Feb; 145(5):239-42. PubMed ID: 15024936
[No Abstract] [Full Text] [Related]
19. The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine in node-positive pancreatic cancer.
Kurosaki I; Hatakeyama K
Hepatogastroenterology; 2004; 51(57):634-7. PubMed ID: 15143880
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Van Laethem JL; Hammel P; Mornex F; Azria D; Van Tienhoven G; Vergauwe P; Peeters M; Polus M; Praet M; Mauer M; Collette L; Budach V; Lutz M; Van Cutsem E; Haustermans K
J Clin Oncol; 2010 Oct; 28(29):4450-6. PubMed ID: 20837948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
